Ardent Health (ARDT) Q4 FY2024 earnings: revenue $1.6 billion

Ardent Health, Inc. (ARDT) reported revenue of $1.6 billion for Q4 FY2024, the quarter ended 31 December 2024. Net income was $114 million, and diluted earnings per share $0.84. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue$1.6 billion

Net income$114 million

Diluted EPS$0.84

QuarterQ4 FY2024ended 31 December 2024

The quarter, against the one before and a year earlier

Line	Q4 FY2024	Q3 FY2024	A year earlier	Change on the year
Revenue	1,606	1,450	n/a	n/a
Operating income	167	57.1	n/a	n/a
Operating margin	10.4%	3.9%	n/a
Pre-tax income	167	57.1	n/a	n/a
Income tax	26.4	11.1	n/a	n/a
Effective tax rate	15.8%	19.4%	n/a
Net income	114	26.3	n/a	n/a
Net margin	7.1%	1.8%	n/a
Diluted EPS	$0.84	$0.19	n/a	n/a

$ million except per share.

Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q4 FY2024	Q3 FY2024	A year earlier	Change on the year
Operating cash flow	120	89.7	n/a	n/a
Capital expenditure	81.3	43.5	n/a	n/a
Free cash flow	38.3	46.2	n/a	n/a
Free cash flow margin	2.4%	3.2%	n/a
Cash from investing	-105	-44.5	n/a	n/a
Cash from financing	-20.5	183	n/a	n/a
Depreciation and amortisation	37.9	36.8	n/a	n/a
Dividends paid	0.0	0.0	n/a	n/a
Diluted shares, weighted	133m	138m	n/a	n/a
Shares outstanding at period end	143m	0	n/a	n/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q4 FY2024	Q3 FY2024	A year earlier	Change on the year
Shareholders' equity	1,131	1,006	n/a	n/a
Non-controlling interest	390	379	n/a	n/a
Redeemable equity	1.2	2.4	n/a	n/a
Debt	1,114	1,096	n/a	n/a
Operating lease liabilities	1,141	n/a	n/a	n/a
Finance lease liabilities	15.3	n/a	n/a	n/a
Other liabilities	1,164	2,317	n/a	n/a
Total liabilities and equity	4,956	4,800	n/a	n/a
Fixed assets	862	815	n/a	n/a
Goodwill	852	852	n/a	n/a
Cash and equivalents	557	563	n/a	n/a
Receivables	743	706	n/a	n/a
Inventory	115	108	n/a	n/a
Other assets	1,827	1,756	n/a	n/a
Total assets	4,956	4,800	n/a	n/a

Questions

What was Ardent Health's revenue in Q4 FY2024?

Ardent Health (ARDT) reported revenue of $1.6 billion for Q4 FY2024, the quarter ended 31 December 2024.

How much did Ardent Health earn in Q4 FY2024?

Net income for Q4 FY2024 was $114 million, and diluted earnings per share $0.84.

When did Ardent Health report Q4 FY2024 results?

Ardent Health filed its 10-K for the year that ended with the quarter on 27 February 2025; the fourth quarter is the year less the first three.

Quarterly results, the last 12 quarters

	Q2 FY2023	Q3 FY2023	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026
Revenue	1,369	1,378	1,439	1,471	1,450	1,606	1,497	1,645	1,577	1,605	1,602	1,622
Operating income	67.8	46.0	56.6	82.2	57.1	167	74.2	122	-2.2	92.4	74.6	43.2
Operating margin	5%	3%	4%	6%	4%	10%	5%	7%	-0%	6%	5%	3%
Pre-tax income	67.8	46.0	56.6	82.2	57.1	167	74.2	122	-2.2	92.4	74.6	43.2
Tax rate	18%	16%	19%	19%	19%	16%	21%	22%	n/a	20%	22%	20%
Net income	33.1	20.8	27.0	42.8	26.3	114	41.4	73.0	-23.5	45.0	39.9	16.9
Net margin	2%	2%	2%	3%	2%	7%	3%	4%	-1%	3%	2%	1%
Diluted EPS	$0.26	$0.17	$0.21	$0.34	$0.19	$0.84	$0.29	$0.52	-$0.17	$0.32	$0.28	$0.12
Operating cash flow	n/a	88.7	-14.7	120	89.7	120	-24.8	117	154	223	-60.2	197
Capital expenditure	n/a	25.0	23.8	38.9	43.5	81.3	22.9	46.2	58.8	84.0	28.1	38.7
Free cash flow	n/a	63.6	-38.5	81.5	46.2	38.3	-47.7	71.3	95.6	139	-88.3	158
Dividends paid	n/a	0.0	0.0	0.0	0.0	0.0	n/a	n/a	n/a	n/a	n/a	n/a
Shares outstanding	143m	143m	143m	486m	0	143m	143m	143m	143m	143m	143m	142m
Filing	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 December 2024, filed 27 February 2025: the filing.